UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Is acute myeloid leukemia a liquid tumor?

International journal of cancer, 2013-08, Vol.133 (3), p.534-543

2013

Link zum Volltext

Verfügbarkeit prüfen

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia

Cancer, 2014-02, Vol.120 (3), p.373-380

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment with lenalidomide modulates T‐cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia

Cancer, 2011-09, Vol.117 (17), p.3999-4008

2011

Link zum Volltext

Verfügbarkeit prüfen

The biology and therapy of adult acute lymphoblastic leukemia

Cancer, 2003-10, Vol.98 (7), p.1337-1354

2003

Link zum Volltext

Verfügbarkeit prüfen

Very long‐term follow‐up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy

Cancer, 2012-06, Vol.118 (12), p.3116-3122

2012

Link zum Volltext

Verfügbarkeit prüfen

Complete cytogenetic and molecular responses to interferon‐α‐based therapy for chronic myelogenous leukemia are associated with excellent long‐term prognosis

Cancer, 2003-02, Vol.97 (4), p.1033-1041

2003

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy with arsenic trioxide, all‐trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia

Cancer, 2007-04, Vol.109 (7), p.1355-1359

2007

Link zum Volltext

Verfügbarkeit prüfen

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

Cancer, 2013-08, Vol.119 (15), p.2728-2736

2013

Link zum Volltext

Verfügbarkeit prüfen

Chronic myelogenous leukemia: A review and update of therapeutic strategies

Cancer, 2003-08, Vol.98 (3), p.437-457

2003

Link zum Volltext

Verfügbarkeit prüfen

Adult acute lymphoblastic leukemia

Cancer, 2010-03, Vol.116 (5), p.1165-1176

2010

Link zum Volltext

Verfügbarkeit prüfen

Adult Acute Lymphoblastic Leukemia: Concepts and Strategies

Cancer, 2010-03, Vol.116 (5), p.1165-1176

2010

Link zum Volltext

Verfügbarkeit prüfen

Long‐term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial

British journal of haematology, 2016-09, Vol.174 (5), p.760-766

2016

Link zum Volltext

Verfügbarkeit prüfen

The long non‐coding RNA LINC00941 and SPRR5 are novel regulators of human epidermal homeostasis

EMBO reports, 2019-02, Vol.20 (2), p.n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome : Predictive prognostic models for outcome

Cancer, 2006-03, Vol.106 (5), p.1090-1098

2006

Link zum Volltext

Verfügbarkeit prüfen

Cause of death in patients with lower‐risk myelodysplastic syndrome

Cancer, 2010-05, Vol.116 (9), p.2174-2179

2010

Link zum Volltext

Verfügbarkeit prüfen

Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia

Cancer, 2008-10, Vol.113 (8), p.2097-2101

2008

Link zum Volltext

Verfügbarkeit prüfen

Outcome of adults with acute lymphocytic leukemia after second salvage therapy

Cancer, 2008-12, Vol.113 (11), p.3186-3191

2008

Link zum Volltext

Verfügbarkeit prüfen

Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration

Cancer, 2010-12, Vol.116 (24), p.5568-5574

2010

Link zum Volltext

Verfügbarkeit prüfen

Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

Cancer, 2015-07, Vol.121 (14), p.2375-2382

2015

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia

Cancer, 2008-02, Vol.112 (4), p.837-845

2008

Link zum Volltext

Verfügbarkeit prüfen

Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long‐term outcome of patients with early chronic myeloid leukemia in chronic phase

Cancer, 2009-08, Vol.115 (16), p.3709-3718

2009

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease

Cancer, 2012-01, Vol.118 (1), p.112-117

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 150

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(148)

Publikationsform

Artikel
(150)

Sprache

Englisch
(150)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(115)
Life Sciences & Biomedicine
(108)
Science & Technology
(108)
Middle Aged
(99)
Biological And Medical Sciences
(96)
Medical Sciences
(96)
Oncology
(89)
Aged
(84)
Adult
(82)
Female
(79)
Male
(79)
Hematologic And Hematopoietic Diseases
(75)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(72)
Tumors
(61)
Treatment Outcome
(48)
Aged, 80 And Over
(47)
Prognosis
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(34)
Adolescent
(31)
Antineoplastic Agents - Therapeutic Use
(29)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Online Library
(150)
Elektronische Zeitschriftenbibliothek - Freely accessible e-journals
(149)
Wiley Online Library
(148)
Journals@Ovid
(146)
NUS Single-Journal Subscriptions
(116)
SpringerLink Series
(88)
IngentaConnect Journals
(8)
IngentaConnect Journals
(2)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer
(116)
British Journal Of Haematology
(16)
American Journal Of Hematology
(12)
Embo Reports
(2)
Cancer Medicine
(1)
European Journal Of Haematology
(1)
International Journal Of Cancer
(1)
Reviews In Clinical And Experimental Hematology
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is acute myeloid leukemia a liquid tumor?

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia

Treatment with lenalidomide modulates T‐cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia

The biology and therapy of adult acute lymphoblastic leukemia

Very long‐term follow‐up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy

Complete cytogenetic and molecular responses to interferon‐α‐based therapy for chronic myelogenous leukemia are associated with excellent long‐term prognosis

Combination therapy with arsenic trioxide, all‐trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

Chronic myelogenous leukemia: A review and update of therapeutic strategies

Adult acute lymphoblastic leukemia

Adult Acute Lymphoblastic Leukemia: Concepts and Strategies

Long‐term follow‐up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Long‐term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial

The long non‐coding RNA LINC00941 and SPRR5 are novel regulators of human epidermal homeostasis

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome : Predictive prognostic models for outcome

Cause of death in patients with lower‐risk myelodysplastic syndrome

Hyper‐CVAD plus nelarabine in newly diagnosed adult T‐cell acute lymphoblastic leukemia and T‐lymphoblastic lymphoma

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia

Outcome of adults with acute lymphocytic leukemia after second salvage therapy

Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration

Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia

Significance of suboptimal response to imatinib, as defined by the European LeukemiaNet, in the long‐term outcome of patients with early chronic myeloid leukemia in chronic phase

Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease

Aktive Filter

Suchergebnisse filtern